Clinical Trial Update: Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation [Phase 1]

View source ↗

Summary

Phase 1 study evaluating BAY94-9392 PET imaging in healthy volunteers and patients with cancer or inflammatory disease, assessing radiation dosimetry, metabolis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Inflammatory Disease

Drugs mentioned

• BAY94-9392

Snippet

Sponsor: Life Molecular Imaging SA | Conditions: Diagnostic Imaging, Neoplasms | Phase 1 | Status: COMPLETED